GlassScriptPhysician profile
Randy Alan Trimpey
NPI 1588668255
$387.14
in general payments reported to CMS, 2019-2025
13 companies · $85.65 in 2025
The $85.65 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.77 · 2022: $149 · 2023: $132 · 2025: $85.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $217.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $67.80 | 2021-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $62.59 | 2022-2023 | Vraylar |
| Glaxosmithkline, LLC. | $41.91 | 2023-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Pfizer INC. | $37.16 | 2022-2023 | |
| Corium, LLC | $28.21 | 2022-2023 | Azstarys |
| Abbott Laboratories | $25.93 | 2023 | Freestyle Libre 3 |
| Dexcom, INC. | $20.54 | 2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $18.55 | 2022 | |
| Lilly USA, LLC | $18.05 | 2023 | Mounjaro |
| Otsuka America Pharmaceutical, INC. | $17.63 | 2025 | Rexulti |
| Amgen INC. | $17.19 | 2023 | Prolia, Evenity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.69 | 2025 | Xifaxan |
| Idorsia Pharmaceuticals US INC | $14.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randy Trimpey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.